参考文献/References:
[1]段江曼,高福生,王策,等.大肠癌[M].北京:中国医药科技出版社,2016:82-95.
[2]方兴国,杨芳,李红平.鸦胆子油乳注射液对大肠癌患者血清COX-2和PGE2水平的影响[J].中国老年学杂志,2018,38(15):3636-3638.
[3]黄新恩,刘梦琰,孙健,等.鸦胆子油乳注射液对大肠癌患者的临床疗效及可能机制研究[J].中药材,2016,39(11):2640-2642.
[4]张朴花.鸦胆子油乳联合化疗方案治疗晚期结直肠癌患者的临床疗效[J].医疗装备,2016,29(23):72-73.
[5]白晓娟,罗凯.鸦胆子油乳注射液直肠滴入联合动脉灌注化疗药物治疗中晚期直肠癌30例[J].陕西中医,2009,30(10):1324-1325.
[6]原杨.鸦胆子油乳联合复方苦参辅助治疗对结直肠癌根治术患者预后的影响[J].结直肠肛门外科,2016,22(3):328-331.
[7]Hinkal GW,Gatza CE,Parikh N,et al.Altered senescence, apoptosis, and DNA damage response in a mutant p53 model of accelerated aging[J].Mechanisms of Ageing & Development,2009,130(4):262-271.
[8]秦婷婷,洪帆,徐洋,等.鸦胆子油乳注射液联合卡培他滨治疗晚期结肠癌的疗效分析[J].现代消化及介入诊疗,2014,19(3):156-159.
[9]杨凡,闫涵,庞歆桥,等.鸦胆子油联合化疗治疗结直肠癌效果的系统评价[J].山东医药,2016,56(13):45-46,47.
[10]刘梦琰,孙健,黄新恩,等.鸦胆子油乳注射液对大肠癌患者的临床疗效及可能机制研究[J].中药材,2016,39(11):2640-2642.
[11]卜金钟,钟春生.鸦胆子油乳注射液辅助治疗中晚期大肠癌的临床疗效评价[J].淮海医药,2010,1(12):63-64.
[12]李绮云,林王美,黄康龙.FOLFOX6方案联合鸦胆子油乳治疗转移性大肠癌的临床观察[J].肿瘤基础与临床,2013,26(01):16-18.
[13]聂红霞.鸦胆子油乳注射液联合folfox4方案治疗晚期结肠癌患者疗效观察[J].中国社区医师(医学专业),2012,32(10):56-58.
[14]蒋峻.用鸦胆子油乳联合FOLFIRI化疗方案治疗晚期结直肠癌的效果分析[J].当代医药论丛,2015,13(3):271-273.
[15]罗秀玲,魏万高,姚彪.鸦胆子油乳注射液配合化疗治疗大肠癌术后临床观察[J].临床医药实践,2009,18(32):2216-2217.
[16]闫晓红,刘尧,汪华,等.鸦胆子油乳联合化疗方案治疗晚期结直肠癌临床疗效观察[J].当代医学,2013,3(19):9-11.
[17]周俊文,马翔,翟所迪.如何认识和解读Meta分析[J].兰州大学学报(医学版),2016,42(1):37-41.
[18]杨克虎,田金徽,李伦,等.网状Meta分析方法与实践[M].北京:中国医药科技出版社,2017:1-50.
相似文献/References:
[1]王琳琳,刘 蕾.CDX2和CYP24A1在大肠癌中的表达[J].医学信息,2018,31(07):72.[doi:10.3969/j.issn.1006-1959.2018.07.023]
WANG Lin-lin,LIU Lei.The Expression of CDX2 and CYP24A1 in Colorectal Cancer[J].Journal of Medical Information,2018,31(21):72.[doi:10.3969/j.issn.1006-1959.2018.07.023]
[2]陈倩如.大肠癌住院病例临床特征分析[J].医学信息,2019,32(02):145.[doi:10.3969/j.issn.1006-1959.2019.02.042]
CHEN Qian-ru.Analysis of Clinical Features of Hospitalized Cases of Colorectal Cancer[J].Journal of Medical Information,2019,32(21):145.[doi:10.3969/j.issn.1006-1959.2019.02.042]
[3]刘 芬,刘秀峰.基于SMOTEboost的大肠癌不平衡数据集的症型分类研究[J].医学信息,2018,31(23):10.[doi:10.3969/j.issn.1006-1959.2018.23.003]
LIU Fen,LIU Xiu-feng.Symptomatic Classification of Colorectal Cancer Unbalanced Data Set Based on SMOTEboost[J].Journal of Medical Information,2018,31(21):10.[doi:10.3969/j.issn.1006-1959.2018.23.003]
[4]李 洁.大肠癌患者的灵性需求现状及影响因素分析[J].医学信息,2021,34(05):151.[doi:10.3969/j.issn.1006-1959.2021.05.043]
LI Jie.Analysis of the Status Quo of Spiritual Needs and Influencing Factors of Patients with Colorectal Cancer[J].Journal of Medical Information,2021,34(21):151.[doi:10.3969/j.issn.1006-1959.2021.05.043]
[5]孔 娜,王建刚,殷 芳,等.幽门螺旋杆菌感染与大肠息肉及大肠癌的关系研究[J].医学信息,2021,34(11):35.[doi:10.3969/j.issn.1006-1959.2021.11.011]
KONG Na,WANG Jian-gang,YIN Fang,et al.Study on the Relationship Between Helicobacter Pylori Infection and Colorectal Polyps and Colorectal Cancer[J].Journal of Medical Information,2021,34(21):35.[doi:10.3969/j.issn.1006-1959.2021.11.011]